Histamine H3 receptor therapeutics have been proposed for several diseases such as schizophrenia, attention deficit hyperactivity disorder, Alzheimer's disease and obesity. The gene discussed is HRH3; the disease is early-onset autosomal dominant Alzheimer disease.